PCN87 A COST-EFFECTIVENESS ANALYSIS OF BEVACIZUMAB PLUS...

PCN87 A COST-EFFECTIVENESS ANALYSIS OF BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE (BCG) COMPARED WITH PEMETREXED PLUS CISPLATIN (PC) FOR THE TREATMENT OF ADVANCED OR RECURRENT NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY

HG Bischoff, D Heigener, C Wiesner, S Walzer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74338-2
File:
PDF, 72 KB
english, 2009
Conversion to is in progress
Conversion to is failed